FBL1: Liz Parrish - Longevity, Death, & Gene Therapies with Patient Zero

from The Singularity Discussion Series · host Singularity University

This week we're joined by Elizabeth Parrish, CEO of biotech and longevity company, Bioviva. Liz gained worldwide renown in 2015 when she flew to Colombia to inject herself with one of the gene therapies her company was testing, making her patient zero. In this conversation, we explore her motivations for such drastic measures, the current state of life-extension and longevity research, and how she believes society will be shaped by this rapidly advancing biotechnology.

Episode metadata supplied by the publisher feed · Published Jun 16, 2019

Embed this episode

Attribution link and audio player

Ready to play

FBL1: Liz Parrish - Longevity, Death, & Gene Therapies with Patient Zero

0:00 42:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Singularity Discussion Series?

This episode is 42 minutes long.

When was this The Singularity Discussion Series episode published?

This episode was published on June 16, 2019.

Can I download this The Singularity Discussion Series episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!